ASPR pauses distribution of bamlanivimab and etesevimab in R.I. due to variant

Jun 16, 2021 - 02:51 PM
HHS Logo web sized 900x400

Rhode Island health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence of the SARS-CoV-2 P.1 and B.1.351 variants, which are not susceptible to the combination therapy, the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response announced today.

ASPR also continues to suspend distribution of bamlanivimab and etesevimab in Arizona, California, Florida, Illinois, Indiana, Massachusetts, Oregon and Washington due to spread of one or both of these variants in those states.

The Food and Drug Administration recommends providers in R.I. and these other states use the alternative monoclonal antibody therapies REGEN-COV or sotrovimab, which are likely to remain active against these variants, ASPR said. The announcement does not affect other states, but providers should monitor the frequency of the P.1 and B.1.351 variants in their region and review the fact sheets for each authorized monoclonal antibody therapy for details regarding specific variants and resistance, ASPR said.

Related News Articles

Headline
CDC adopts ACIP recommendations for COVID-19, chickenpox vaccines
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
FDA seeks feedback on measuring AI-enabled medical device performance
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
Olympus recalls endoscope needles
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
ACIP recommends patients consult their provider for COVID-19 vaccine
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
HHS announces efforts to improve long COVID care 
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
FDA issues serious recall for electric wheelchair joysticks
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…